Table 1 Correlations between EN2 expression and clinicopathologic features in 165 colorectal cancer patients.
From: EN2 as an oncogene promotes tumor progression via regulating CCL20 in colorectal cancer
Clinicopathological feature | Â | Expression of EN2 | Â | Â | |
---|---|---|---|---|---|
Total (165) | Low (n = 64) | High (n = 101) | χ2 | P-value | |
Age (years) | Â | Â | Â | 0.984 | 0.321 |
 ≤65 | 90 | 38 | 52 |  |  |
 >65 | 75 | 26 | 49 |  |  |
Gender | Â | Â | Â | 2.457 | 0.117 |
 Male | 96 | 32 | 64 |  |  |
 Female | 69 | 32 | 37 |  |  |
Tumor location | Â | Â | Â | 0.011 | 0.915 |
 Colon | 123 | 48 | 75 |  |  |
 Rctum | 42 | 16 | 26 |  |  |
Tumor size | Â | Â | Â | 10.531 | 0.001 |
 ≤5 cm | 77 | 40 | 37 |  |  |
 >5 cm | 88 | 24 | 64 |  |  |
Histology grade | Â | Â | Â | 9.726 | 0.002 |
 Well | 78 | 40 | 38 |  |  |
 Moderate/poor | 87 | 24 | 63 |  |  |
TNM stage | Â | Â | Â | 19.498 | <0.001 |
 I/II | 61 | 37 | 24 |  |  |
 III/IV | 104 | 27 | 77 |  |  |